In a recent interview with CNBC-TV18, Shivangi Sarda from Motilal Oswal Financial Services shared her expert insights on three top stock picks, MCX, Maruti Suzuki and Tata Consumer.

Share Market Live

NSE

Shivangi Sarda's first stock pick is Multi Commodity Exchange of India (MCX). She pointed out that MCX has recently exhibited a flag formation breakout on both the daily and weekly charts. Additionally, the stock has held up well, finding strong support after an impressive rally. Most notably, it has negated its lower highs formation, indicating a shift in momentum.

Sarda is optimistic about MCX and recommended a buy position, setting a target price of Rs 1,930 with a stop loss at Rs 1,818.

In the last month, MCX surged by over 18 percent, making it an attractive prospect for investors looking to capitalize on its upward trajectory.

Maruti Suzuki India, the second stock on Sarda's radar, has been riding a wave of spectacular momentum. Despite a minor correction, the stock rebounded impressively, showcasing its resilience and ability to outperform market expectations.

Sarda suggested a buy position for Maruti Suzuki India, setting a target price near Rs 11,100. She also highlighted the importance of keeping an eye on the support level at Rs 10,470.

Over the past month, the stock has gained more than 11 percent, solidifying its position as a promising candidate for investors seeking growth opportunities.

Sarda's third pick is Tata Consumer Products, a stock that has piqued her interest due to its positive outlook. She emphasized the favorable risk-reward ratio at its current levels, coupled with significant rollover activity in the market as it approaches the monthly expiry week.

For Tata Consumer Products, Sarda recommended a buy position with a target price of Rs 920 and a stop loss set at Rs 870.

In the past month, the stock has exhibited growth of more than 6 percent, making it an intriguing choice for investors seeking potential gains.

Disclaimer:

The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.